|
Monoclonal antibodies are laboratory-produced
molecules. These are engineered to serve as substitute antibodies that
can restore, enhance, modify or mimic the immune system's attack on cells
that aren't wanted, such as cancer cells. Many monoclonal antibodies have
been approved for treating cancer. |
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Tuesday, January 4, 2022
Monoclonal antibody drugs for cancer: How they work
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment